Skip to main content
Download PDF

Effects of laughter yoga on health-related quality of life in cancer patients undergoing chemotherapy: a randomized clinical trial

BMC Complementary Medicine and Therapies volume 23, Article number: 192 (2023) Cite this article

Abstract

Background

Chemotherapy is associated with a wide range of physical and psychological side effects, so complementary and alternative therapies may be practiced as an independent treatment or combined with the standard ones to improve health-related quality of life of cancer patients. Laughter yoga has predominantly been used as a complementary therapy to enhance health and wellbeing of ordinary people and patients with chronic diseases. However, to date, few studies have evaluated the effects of this modern exercise on cancer patients undergoing chemotherapy in clinical settings, to the best of the authors’ knowledge. the present study aimed to investigate the effects of Laughter Yoga on the health-related quality of life of cancer patients undergoing chemotherapy.

Methods

This study was a two-group randomized clinical trial on 69 cancer patients undergoing chemotherapy at Reza Radiotherapy and Oncology Center, Iran in 2018. Patients were randomly divided into intervention and control groups. The intervention group received laughter yoga for four sessions at one-week intervals. Each session consists of one part and lasts for 20–30 min. Patients’ health-related quality of life was assessed before and after the laughter yoga sessions using Quality of Life Questionnaire European Organization for Research and Treatment of Cancer (EORTC QLQ-C30) version 3.0. SPSS Statistics (v.20 software was used to conduct Chi-square, independent t-test, Mann-Whitney, Wilcoxon and paired t-tests analyses of the data.

Results

The number of participants in intervention and control groups were 34 and 35, there was no significant difference of demographic and disease related characteristics and pre-intervention HRQOL between two groups. In the intervention group, there is significant difference between pre- and post-intervention scores (Mean ± Standard Deviation) of emotional functioning (12.99 ± 10.49), physical functioning (0.78 ± 6.08), role functioning (3.43 ± 7.97), fatigue (-8.82 ± 22.01), pain (-8.33 ± 11.78), sleep disturbance (-15.68 ± 18.77), and global health and quality of life (6.37 ± 5.04) (p < 0.05). There was no significant change in the control group. Participants reported no adverse events.

Conclusions

A structured laughter yoga intervention in a hospital setting effectively improved health-related quality of life for cancer patients undergoing chemotherapy. Benefits to many patients could be expected if this would become a part of routine care.

Trial Registration

This study was registered in the Iranian Registry of Clinical Trials (no. IRCT20180429039463N1) on 21/08/2018.

Peer Review reports

Introduction

Cancer accounts for 9% of all deaths across the world, and the second leading cause of mortality in developing nations following cardiovascular diseases [1]. The age-standardized rates in cancer incidence and mortality were estimated to be 152.7 and 94.0, respectively, per 100,000 populations in Iran in 2020 [2, 3]. Most cancer patients receive chemotherapy as a definitive treatment option to increase their life expectancy and survival rate [4,5,6]. This type of cancer treatment gives rise to an extensive range of physical and psychological impacts related to patients’ health-related quality of life (HRQOL) [7,8,9]. Health-related quality of life (HRQOL) refers to the state of wellbeing expressed by the participants during the period of illness or treatment with regard to ability to perform daily activities (including physical, mental, and social functions), experience of physical symptoms and difficulties (such as pain, nausea/vomiting, fatigue, sleep disturbance, loss of appetite, financial difficulty, etc.), and perception towards their overall health and quality of life [10,11,12]. Being endowed with higher HRQOL can thus result in better acceptance and reduced complications in patients once diagnosed [12]. Boosting HRQOL also diminishes the accompanying medical and healthcare costs [13]. For the purpose of mitigating the discomforts associated with the disease and treatment, and then improve HRQOL in patients, complementary and alternative therapy may be utilized as an independent treatment or one combined with standard therapy [14, 15].

Laughter yoga is a type of complementary therapy which also incorporates some other components including mild type of physical exercises. This type of treatment combines unconditional laughter with yoga breathing practices and yoga stretching poses so that patients laugh different from jokes or humor programs [16]. Some scholars believe that both real and fake laughter can have the same effects on the body [17,18,19,20,21]. Laughter yoga, first introduced by an Indian physician, comprised of a number of exercises together with laughter [16]. It includes four main steps: clapping and body movement, deep breathing, childlike playfulness, and laughter exercises. Laughter also triggers the release of endorphins and decreases stress hormones that make a person feel good [17,18,19,20,21]. It means that laughter yoga releases a rush of stress-busting hormones, like epinephrine and dopamine [22]. A good, hearty laugh from the belly also oxygenates the body and provides an emotional and physical release, removing tension and leaving the body relaxed so that makes a person feel good. This modern exercise is also an easy, cost-effective, and affordable method that can maintain mental well-being in patients. It is also possible to teach laughter yoga in patients so that they can practice this by themselves, which helps increase their self-care management [16, 17, 23]. Many studies in Iran and other countries evaluated the effectiveness of laughter yoga to enhance the health and wellbeing of ordinary people and patients with chronic diseases [16, 24,25,26]. However, there are few studies on its effect among cancer patients undergoing chemotherapy in a clinical setting [14]. According to Namazi-Nia et al., laughter yoga had enhanced mental well-being scores in cancer patients undergoing chemotherapy [23]. In the study by Farifteh et al., laughter yoga in cancer patients showed reduced stress before chemotherapy and elevated HRQOL [27]. To date, in spite of the beneficial effects of this therapeutic technique, little research has been conducted in this field, particularly for improving HRQOL in cancer patients undergoing chemotherapy.

The purpose of this study was to determine the effect of laughter yoga on HRQOL in cancer patients undergoing chemotherapy. We hypothesized that implementing the laughter yoga program will significantly promote HRQOL in patients undergoing chemotherapy.

Methods

O trial design

This study was a single-center, two-group randomized clinical trial comparing the effects of structured laughter yoga program in cancer patients before chemotherapy. The study is reported using the CONSORT (Consolidated Standards of Reporting Trials) checklist.

O participants

The inclusion criteria were cancer patients with an age range of 18–60, having non-metastatic type of cancers, no auditory-visual problems, undergoing four sessions of chemotherapy per month, absence of stomatitis symptoms, no upper gastrointestinal (UGI) cancer, attending no simultaneous radiotherapy programs, as well as the mental and physical ability to perform laughter yoga. The exclusion criteria were chronic stress during the study approved by the psychologist of the center, disease exacerbation and the need for intensive care services, changes in chemotherapy programs due to thrombocytopenia or any other factors, and modifications in chemotherapy drug regimen. This study was a two-group randomized clinical trial on 69 cancer patients undergoing chemotherapy. It was conducted at the at Reza Radiotherapy and Oncology Center, Iran, in 2018. Patients were randomly divided into intervention and control groups., Mashhad, Iran, between October 2018 and June 2019.

O intervention

The intervention group received laughter yoga for four sessions with one-week intervals. Each session lasts for 20–30 min and it consists of 15 steps of laughter yoga performed consecutively. And each laugh lasts approximately 30 to 45 s. This intervention was provided by researchers who had completed laughter yoga training course from the laughter yoga instructor and participants were supervised during each session. Laughter yoga sessions were held in three groups of 8, 12, and 14 cancer patients. The intervention was carried out before the chemotherapy according to the protocol. The four sessions of the intervention were performed in a standing position following the 15 steps (Supplementary Material 1).

In the control group, only routine self-care training was conducted by the researchers in the meeting hall in the form of face-to-face education and the use of pamphlets. This program was implemented exactly the same for the intervention group with 10 min one session each week for four weeks. The educational content was developed after reviewing the related literature, up-to-date studies, guidelines of the National Cancer Prevention and Control Program published by the Ministry of Health and Medical Education (MHME), World Health Organization [28], and experts in the field of health psychology for cancer patients. The education program contents included infection prevention, oral hygiene, skin and hair health, nausea and vomiting, improved nutrition and fatigue.

O outcomes

The primary outcome of this trial was HRQOL, which was assessed using EORTC QLQ-C30 (European Organization for the Research and Treatment of Cancer Quality of Life Questionnaire version 3). Demographic information was also collected using a structured questionnaire.

Demographic information questionnaire had 6 questions about age, frequency of chemotherapy, sex, type of cancer, previous chemotherapy experience, and experience of participating in program. This questionnaire was completed through an interview before the intervention.

EORTC tool contained 30 items with five functioning domains, nine symptoms, and Global HRQOL status. HRQOL means subjective feeling of patients regarding their overall health and quality of life. The five functioning domains included physical functioning, role functioning, emotional functioning, cognitive functioning, and social functioning. The nine symptoms included fatigue, nausea/vomiting, pain, shortness of breath, sleep disturbance, appetite loss, constipation, diarrhea, and financial hardship. Raw score obtained from the rating given by the participants on questions was converted into transformed score ranging from zero to 100 as per the scoring manual. A higher value of HRQOL and functional scores, and lower value of symptoms and single items represents better health and wellbeing [29]. This questionnaire had shown good internal reliability in several studies to determine HRQOL in cancer patients [30, 31]. A study found that the Persian version of EORTC QLQ-C30 was a reliable and valid tool and could be used in epidemiological and clinical research studies on cancer. The Cronbach’s alpha coefficient in most domains of the questionnaire was more than 0.7 and the convergence validity was 41–79% [32]. As used in this study, the internal consistency reliability of EORTC QLQ-C30 was Cronbach’s alpha = 0.81.

The study questionnaires were completed before and after the laughter yoga sessions by the cancer patients, through interviews in a quiet room at the meeting hall next to the chemotherapy Center. First baseline demographic data were taken and initial assessment of HRQOL was done. Final assessment of HRQOL was done after four weeks, when laughter yoga intervention was delivered to the intervention group and self-care training education was given to the control group. Participants in both groups received their routine chemotherapy in between the assessments.

O sample size and randomization

The sample size was determined by 34 patients in each group based on the results of a pilot study on 10 participants in each group using the comparison of two means formula with 95% confidence interval and 80% test power. Assuming the possibility of participants being lost to follow up loss of some cases, and to give more assurance to the completion of study with required sample size, 39 cancer patients in each group were included in the present study. Among them, five cases from the intervention group and four individuals from the controls were lost to follow up. Finally, 69 cancer patients remained in the study (Fig. 1).

Fig. 1
figure 1

CONSORT Flow Chart of participants

Full size image

The first author of the study, as the research coordinator, referred to the chemotherapy unit and extracted the list of patients undergoing chemotherapy. Then introduced oneself to the cancer patients and selected eligible ones with reference to the mentioned criteria. The cancer patients were selected based on the convenience sampling method and then divided into the intervention and control groups using random sequence generated by the SPSS Statistics (v.20) software, kept in a closed envelope. Upon providing an individual oral explanation about the research objectives and methodology, informed written consent was obtained from the cancer patients in both groups. Although it is difficult to blind the participants in this trial, the outcome assessors and statisticians were blinded to the type of intervention.

O statistical methods

The data was analyzed using the SPSS Statistics (v.20) software total of 69 cancer patients out of 78 were included in the data analysis as nine cancer patients were lost to follow -up. Questionnaire was checked for completeness just after the participants returned it. The descriptive statistics (viz., frequency distribution, mean, and standard deviation) were used to describe and categorize the data. Inferential statistics including the Chi-square test, independent-samples t-test, and Mann-Whitney U test were used to test the research hypothesis. Wilcoxon signed-rank test and paired-samples t-tests were further employed for intra-group comparisons. The normality of the quantitative variables was correspondingly assessed by the Kolmogorov-Smirnov test. The significance level of 0.05 was set for all the tests in this study.

Results

390 patients were assessed for eligibility. Once the desired sample size was reached, recruitment efforts ended. The 78 eligible candidates were randomly allocated into intervention (n = 39) and control (n = 39). The final number of participants available for comparison of baseline and flow up data was 69. The number of participants lost to follow up was 5 in the intervention group and 4 in control group. Thus, the number of participants in the final analysis was 34 in intervention group and 35 in control group (Fig. 1).

The majority of patients in the intervention (n = 22, 67.7%) and control (n = 24, 68.6%) groups were females. There was no significant difference between two groups in terms of other demographic and disease data (p > 0.05) (Table 1).

Table 1 General baseline characteristics of the participant’s
Full size table

At the pre-intervention stage, the mean scores of the physical function, role function, emotional function, cognitive function and social function in the intervention and control groups were not statistically significant (p > 0.05). But at at the post test the mean scores of the three functional domains such as physical functioning, role functioning and emotional functioning in the intervention group was significantly higher than that in the control group respectivly. It means that the mean scores of the physical functioning domain at the post-test in the intervention group (66.27 ± 17.59) was significantly higher than that in the control group (60.57 ± 18.81) (p < 0.05) Also mean scores of the role functioning domain in the intervention group (71.08 ± 25.06) was significantly higher than that in the control group (65 ± 76 ± 25.81) (p < 0.05). And emotional functioning domain in the intervention group (80.88 ± 16.60) was significantly higher than that in the control group (66.19 ± 26.19) (p < 0.05), (Table 2).

Table 2 Scores of functional domains of hetalth-related quality of life
Full size table

Regarding the symptoms and single items at baseline, the mean scores of the nausea/vomiting, fatigue, pain, dyspnea, sleep, appetite, constipation, diarrhea, financial and HRQOL (overall health and quality of life) in the intervention and control groups were not statistically significant (p > 0.05) At post-test, the mean scores of fatigue and pain in the intervention group were significantly lower than the control group (p < 0.05) (Table 3).The mean scores of the overall QOL status at baseline for the intervention and control groups were not statistically significant (p = 0.167) as well as in the post-test (p = 0.757). However, in the intra-group comparisons, the overall QOL status mean score in the post-intervention stage increased significantly (p < 0.001) (Table 3). No adverse effects were reported by the participants during the study period.

Table 3 Scores of symptoms and single items domains of health-related quality of life
Full size table

Discussion

Our study shed light the effect of laughter yoga on HRQOL in cancer patients undergoing chemotherapy. The findings revealed that the implementation of the laughter yoga has improved the cancer patients HRQOL in terms of emotional functioning, role functioning, physical functioning, and overall HRQOL status. Laughter yoga had also reduced the symptoms of fatigue, pain, sleep disturbance, as well as nausea/vomiting. Implementing laughter yoga to the cancer patients undergoing chemotherapy in clinical settings by trained personnel thus might be helpful to alleviate their difficulties and enhance HRQOL.

In a study in Japan, the findings had demonstrated that laughter accompanied by exercises had boosted emotional functioning in older adults. In the present study, laughter yoga had further augmented emotional functioning among the cancer patients thanks to their positive feelings and emotions, which could in turn have a positive effect on emotional functioning [33]. Laughter yoga in our study has improved the role functioning of the cancer patients, since it led to improvements in mental and psychological issues [17] because mental health was often interrelated with physical health status[34], which could significantly contribute to better overall functioning of cancer patients. In another study laughter yoga sessions held twice a week for a month had correspondingly relieved fatigue in cancer patients undergoing external radiotherapy [35]. Laughter can moderate stress hormones, such as cortisol, increase the body’s readiness to cope with various types of stress [36, 37], and eventually eliminate some symptoms, such as fatigue, and thus promote HRQOL.

Likewise, a four-session fun-laughter program in another study had been able to lower pain in patients with rheumatoid arthritis [38]. Laughter yoga in the present study had similarly alleviated pain among cancer patients undergoing chemotherapy. Researches have also demonstrated that laughter therapy could increase pain tolerance and decrease pain perception through physiological mechanisms involving the release of endorphins [39, 40]. According to another study, four laughter yoga sessions had boosted mental well-being in patients undergoing chemotherapy by 6% [23]. Such studies have supported that the four-session laughter yoga program in the present study had enough dose to achieve the outcomes. As evidenced in another study, laughter yoga had elevated sleep quality scores in patients with Parkinson’s disease [25]. Sleep quality in the present study was also enhanced, as one of the most important benefits of laughter was the release of endorphins, a natural painkiller that could reduce pain and fatigue, and enhance sleep quality in patients undergoing chemotherapy [41]. According to a study in Korea, compulsive laughter in the elderly with depression had boosted their sleep quality by 15.5%, and the mean scores of depression had decreased in the laughter group [42]. Laughter was further effective in promoting a positive mood associated with higher HRQOL [36, 38].

In a study done in Turkey, six sessions of breathing exercises had reduced the incidence rate and severity of nausea/vomiting in breast cancer patients receiving chemotherapy [37]. The present study also showed a reduction in nausea/vomiting, possibly due to the role of breathing component of laughter yoga intervention program. Of note, laughter yoga involves deep breathing exercises with hand and foot movements integrated with laughter [43]. Breathing exercises had been found to reduce tension, anxiety, and stress that could be effective in alleviating nausea/vomiting [44]. Moreover, the Manual of Guidelines for Cancer Care to Patients Undergoing Chemotherapy has recommended deep breathing exercises to prevent nausea/vomiting [37, 45]. Shahidi et al. (2011) found that the effect of laughter yoga had decreased the depression mean scores by 60%, compared with the 37.8% reduction in the exercise group in older women [16]. Additionally, another study had reported that patients with higher HRQOL had shown more interest in assuming a role in society, and they mostly had positive emotions and experiences and less depression, which was in line with the present study [46]. It was thus concluded that laughter yoga can be practiced as a treatment option. In the same way, one study had reported that laughter therapy had improved HRQOL in patients with breast cancer undergoing radiotherapy [35], supporting the usefulness of laughter to cancer patients receiving external radiotherapy. In the present study, laughter yoga had elevated emotional functioning, role functioning, and overall HRQOL status as well as the symptoms of fatigue, pain, and sleep disturbance. The laughter yoga, that generally accompanied by appropriate breathing exercises as well as physical movement, had been used to promote health and wellbeing of apparently healthy people and patients with different ailments [14, 17, 20, 21, 43], as a good intervention to mitigate symptoms and improve the overall health and quality of life of cancer patients undergoing chemotherapy. Since the present study was conducted among appropriately selected patients in a clinical setting, it was easy to bring this intervention into real world and clinical practice in healthcare settings that provide chemotherapy.

The possible mechanism of beneficial effect of laughter yoga seen in the interventional group could be due to the effect of laughter yoga on neurological, endocrine, and immune systems of human body. Laughter has shown to cause release of endorphins and dopamine, decrease of cortisol (stress hormone), and affects production of cytokines in the human body. These effect in turn enhances positive mood and sleep, modulates inflammation, and increases pain tolerance. The real or fake laughter is described to exert similar effect in the body [47, 48]. The positive effect on health of laughter yoga could also be partly due to effect of other components of laughter yoga such as movements, breathing, social connection, and affirmations. This could be the reason of decrease in pain and fatigue, and improvement in sleep, role functioning, emotional functioning, physical functioning, and Global health and quality of life of study participants who received laughter yoga intervention [18,19,20,21, 36,37,38,39,40, 49, 50].

The present study had some limitations. Firstly, the positive effects observed could partly be due to different factors such as the social circumstances created for the laughter yoga intervention, the competency of the laughter yoga instructor, or due to the environment of hospital, or other patients related factors like the level of self-care, and the type of diet they used. Secondly, in the study, the intervention was administered in a moderate group of 8 to 14 participants, for about 20–30 min, and final outcome was assessed after four sessions. Likewise, the intervention was delivered to the patients undergoing chemotherapy and meeting all eligible criteria that consisted of the patients who could walk to do the laughter yoga in standing posture, further study may be needed to see the effects of laughter among the patients who are currently in wheel chair or in bed but still can laugh and do some physical movement and deep breathing, and on those patients who are using other treatment modalities. Finally, since the outcome measure is based on patient reported outcome as measured by structured tool, EORTC QLQ-C30, there can be chances of recall bias [51]. We suggested since this kind of study reflects subjective experiences of the patients, it would be better to incorporate other tools or technique to obtain objectively measurable data that can indicate the specific effect of the intervention in upcoming researches. Though the participants in this study did not reveal any signs of harms of laughter yoga practice, some literatures suggest that such practice may cause discomforts or harms to some individuals [52].

Conclusion

This trial showed that a structured laughter yoga intervention program in a hospital setting delivered by trained instructor for 20–30 min each week for four weeks before chemotherapy effectively improve health-related quality of life of the cancer patients undergoing chemotherapy. This intervention showed enhancement of emotional functioning, improvement overall health and quality of life, and mitigation of fatigue, pain, and sleep disturbance symptoms. Many patients could be benefitted if laughter yoga is incorporated as a complementary therapy in routine clinical care practice.

Data Availability

The datasets generated in the present study are available from the corresponding author upon reasonable request.

Abbreviations

HRQOL:

Health-related quality of life

UGI:

Upper gastrointestinal

EORTC:

European Organization for Research and Treatment of Cancer

MHME:

Ministry of Health and Medical Education

WHO:

World Health Organization

GH/QOL:

Global health and quality of life

References

  1. Fitzmaurice C, Dicker D, Pain A, Hamavid H, Moradi-Lakeh M, MacIntyre MF, Allen C, Hansen G, Woodbrook R, Wolfe C. The global burden of cancer 2013. JAMA Oncol. 2015;1(4):505–27.

    Article  PubMed  Google Scholar 

  2. Ferlay J, Colombet M, Soerjomataram I, Mathers C, Parkin DM, Piñeros M, Znaor A, Bray F. Estimating the global cancer incidence and mortality in 2018: GLOBOCAN sources and methods. Int J Cancer. 2019;144(8):1941–53.

    Article  CAS  PubMed  Google Scholar 

  3. Bray F, Ferlay J, Soerjomataram I, Siegel RL, Torre LA, Jemal A. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. Cancer J Clin. 2018;68(6):394–424.

    Article  Google Scholar 

  4. Chu E, Sartorelli A. Cancer chemotherapy. Lange’s Basic and Clinical Pharmacology 2018:948–76.

  5. Carr C, Ng J, Wigmore T. The side effects of chemotherapeutic agents. Curr Anaesth Crit Care. 2008;19(2):70–9.

    Article  Google Scholar 

  6. Goodman M. Managing the side effects of chemotherapy. Seminars in oncology nursing: 1989: Elsevier; 1989: 29–52.

  7. Burish TG, Tope DM. Psychological techniques for controlling the adverse side effects of cancer chemotherapy: findings from a decade of research. J Pain Symptom Manag. 1992;7(5):287–301.

    Article  CAS  Google Scholar 

  8. Organization WH. Cancer Control: Knowledge Into Action: WHO Guide for Effective Programmes. Policy and Advocacy. Module 6, vol. 6: World Health Organization; 2008.

  9. Liu Y-Q, Wang X-L, He D-H, Cheng Y-X. Protection against chemotherapy-and radiotherapy-induced side effects: a review based on the mechanisms and therapeutic opportunities of phytochemicals. Phytomedicine. 2021;80:153402.

    Article  CAS  PubMed  Google Scholar 

  10. Revicki DA, Osoba D, Fairclough D, Barofsky I, Berzon R, Leidy N, Rothman M. Recommendations on health-related quality of life research to support labeling and promotional claims in the United States. Qual Life Res. 2000;9:887–900.

    Article  CAS  PubMed  Google Scholar 

  11. Ferrans CE, Zerwic JJ, Wilbur JE, Larson JL. Conceptual model of health-related quality of life. J Nurs Scholarsh. 2005;37(4):336–42.

    Article  PubMed  Google Scholar 

  12. Mokhtar ZH, Wong LP, Chong MC, Raimi A, Mansoor A, Al Ajeel LY, Mohajer S. Quality of communication between cancer patients and doctors. Iran Red Crescent Med J. 2021;23(12).

  13. Haji Ali Beigloo R, Mohajer S, Eshraghi A, Mazlom SR. Self-administered medications in cardiovascular ward: a study on patients’ self-efficacy, knowledge and satisfaction. Evid Based Care J. 2019;9(1):16–25.

  14. Oczkowski S. Virtuous laughter: we should teach medical learners the art of humor. Crit Care. 2015;19(1):222.

    Article  PubMed  PubMed Central  Google Scholar 

  15. Nia MN, Mohajer S, Bagheri N, Sarboozi-Hoseinabadi T. The effects of family-centered empowerment model on depression, anxiety, and stress of the family caregivers of patients with COVID-19: a randomized clinical trial. BMC Prim Care. 2022;23(1):185.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  16. Shahidi M, Mojtahed A, Modabbernia A, Mojtahed M, Shafiabady A, Delavar A, Honari H. Laughter yoga versus group exercise program in elderly depressed women: a randomized controlled trial. Int J Geriatr Psychiatry. 2011;26(3):322–7.

    Article  PubMed  Google Scholar 

  17. Kataria M. Laugh for no reason (2011 version). Lokhandwala Complex: Madhuri International; 2011.

    Google Scholar 

  18. Yim J. Therapeutic benefits of laughter in mental health: a theoretical review. Tohoku J Exp Med. 2016;239(3):243–9.

    Article  PubMed  Google Scholar 

  19. Rokade P. Release of endomorphin hormone and its effects on our body and moods: A review. In: International Conference on Chemical, Biological and Environment Sciences: 2011; 2011: 436–438.

  20. Nojabaee A, Salehmoghaddam AR, Mazlom SR, Asgharipour N, Mohajer S. Effect of flourishing promotion program on social health in the elderly. Evid Based Care J. 2018;8(2):39–48.

    Google Scholar 

  21. Bennett MP, Lengacher C. Humor and laughter may influence health: III. Laughter and health outcomes. Evidence-based Complement Altern Med. 2008;5(1):37–40.

    Article  Google Scholar 

  22. Burgdorf J, Colechio M, Stanton E, Panksepp P. Positive emotional learning induces resilience to depression: a role for NMDA receptor-mediated synaptic plasticity. Curr Neuropharmacol. 2017;15(1):3–10.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  23. Sarboozi Hosein َAbadi T, Namazi Nia M, Mazlom SR. Effect of self-determination theory-based discharge program on lifestyle and readmission of patients with heart failure: a clinical trial. Evid Based Care J. 2020;10(1):25–35.

    Google Scholar 

  24. Namazi Nia M, Mohajer S, Ghahramanzadeh M, Mazlom SR. The impact of laughter yoga on mental well-being of cancer patients under chemotherapy. Evid Based Care. 2019;9(3):7–14.

    Google Scholar 

  25. Memarian A, Sanatkaran A, Bahari SM, Habibi SAH. The effectiveness of laughter yoga exercises on anxiety and sleep quality in the elderly suffering from Parkinson’s disease. Aging Psychol. 2017;3(2):85–96.

    Google Scholar 

  26. Mohajer S, Mazlum SR, Rajabzadeh M, Namazinia M. The effect of laughter yoga on depression in cancer patients undergoing chemotherapy: a randomized clinical trial. Hayat. 2022;28(3):284–95.

    Google Scholar 

  27. Farifteh S, Mohammadi-Aria A, Kiamanesh A, Mofid B. The impact of laughter yoga on the stress of cancer patients before chemotherapy. Iran J cancer Prev. 2014;7(4):179.

    PubMed  PubMed Central  Google Scholar 

  28. Group W. The World Health Organization quality of life assessment (WHOQOL): position paper from the World Health Organization. Soc Sci Med. 1995;41(10):1403–9.

    Article  Google Scholar 

  29. Fayers P, Aaronson NK, Bjordal K, Sullivan M. EORTC QLQ–C30 scoring manual. European Organisation for Research and Treatment of Cancer; 1995.

  30. Wallwiener M, Matthies L, Simoes E, Keilmann L, Hartkopf AD, Sokolov AN, Walter CB, Sickenberger N, Wallwiener S, Feisst M. Reliability of an e-PRO tool of EORTC QLQ-C30 for measurement of health-related quality of life in patients with breast cancer: prospective randomized trial. J Med Internet Res. 2017;19(9):e322.

    Article  PubMed  PubMed Central  Google Scholar 

  31. Gadisa DA, Gebremariam ET, Ali GY. Reliability and validity of Amharic version of EORTC QLQ-C30 and QLQ-BR23 modules for assessing health-related quality of life among breast cancer patients in Ethiopia. Health Qual Life Outcomes. 2019;17(1):1–8.

    Article  Google Scholar 

  32. Safaee A, Dehkordi Moghimi B, Tabatabaie S. Reliability and validity of the QLQ-C30 questionnaire in cancer patients. Armaghane danesh. 2007;12(2):79–88.

    Google Scholar 

  33. Hirosaki M, Ohira T, Kajiura M, Kiyama M, Kitamura A, Sato S, Iso H. Effects of a laughter and exercise program on physiological and psychological health among community-dwelling elderly in Japan: Randomized controlled trial. Geriatr Gerontol Int. 2013;13(1):152–60.

    Article  PubMed  Google Scholar 

  34. Ohrnberger J, Fichera E, Sutton M. The relationship between physical and mental health: a mediation analysis. Soc Sci Med. 2017;195:42–9.

    Article  PubMed  Google Scholar 

  35. Rad M, Borzoee F, Mohebbi M. The effect of humor therapy on fatigue severity and quality of life in breast cancer patients undergoing external radiation therapy. J Adv Med Biomedical Res. 2016;24(103):102–14.

    Google Scholar 

  36. Bennett MP, Zeller JM, Rosenberg L, McCann J. The effect of mirthful laughter on stress and natural killer cell activity. 2003.

  37. Aybar DO, Kılıc SP, Çınkır HY. The effect of breathing exercise on nausea, vomiting and functional status in breast cancer patients undergoing chemotherapy. Complement Ther Clin Pract. 2020;40:101213.

    Article  PubMed  Google Scholar 

  38. Yoshino S, Fujimori J, Kohda M. Effects of mirthful laughter on neuroendocrine and immune systems in patients with rheumatoid arthritis. J Rhuematol. 1996;23(4):793–4.

    CAS  Google Scholar 

  39. Weisenberg M, Tepper I, Schwarzwald J. Humor as a cognitive technique for increasing pain tolerance. PAIN®. 1995;63(2):207–12.

    Article  PubMed  Google Scholar 

  40. Zweyer K, Velker B, Ruch W. Do cheerfulness, exhilaration, and humor production moderate pain tolerance? A FACS study. 2004.

  41. Martin RA. Humor, laughter, and physical health: methodological issues and research findings. Psychol Bull. 2001;127(4):504.

    Article  CAS  PubMed  Google Scholar 

  42. Ko HJ, Youn CH. Effects of laughter therapy on depression, cognition and sleep among the community-dwelling elderly. Geriatr Gerontol Int. 2011;11(3):267–74.

    Article  PubMed  Google Scholar 

  43. Yazdani M, Esmaeilzadeh M, Pahlavanzadeh S, Khaledi F. The effect of laughter yoga on general health among nursing students. Iran J Nurs midwifery Res. 2014;19(1):36.

    PubMed  PubMed Central  Google Scholar 

  44. Olcer Z, Oskay U. Stress in high-risk pregnancies and coping methods/Yuksek riskli gebelerin yasadigi stresorler ve stresle bas etme yontemleri. J Educ Res Nurs. 2015;12(2):85–93.

    Google Scholar 

  45. Mohile SG, Dale W, Somerfield MR, Schonberg MA, Boyd CM, Burhenn PS, Canin B, Cohen HJ, Holmes HM, Hopkins JO. Practical assessment and management of vulnerabilities in older patients receiving chemotherapy: ASCO guideline for geriatric oncology. J Clin Oncol. 2018;36(22):2326.

    Article  PubMed  PubMed Central  Google Scholar 

  46. Cummins RA. Subjective well-being, homeostatically protected mood and depression: a synthesis. The exploration of happiness. edn.: Springer; 2013: 77–95.

  47. Morishima T, Miyashiro I, Inoue N, Kitasaka M, Akazawa T, Higeno A, Idota A, Sato A, Ohira T, Sakon M. Effects of laughter therapy on quality of life in patients with cancer: an open-label, randomized controlled trial. PLoS ONE. 2019;14(6):e0219065.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  48. Alici NK, Dönmez AA. A systematic review of the effect of laughter yoga on physical function and psychosocial outcomes in older adults. Complement Ther Clin Pract. 2020;41:101252.

    Article  Google Scholar 

  49. Hajialibeigloo R, Mazlum SR, Mohajer S, Morisky DE. Effect of self‐administration of medication programme on cardiovascular inpatients’ medication adherence and nurses’ satisfaction: a randomized clinical trial. Nurs Open. 2021;8(4):1947.

  50. Miri K, Mohammadi E, Vanaki Z. Trend in the role of licensed practical nurses in health care system: a situational analysis. In: Nursing forum: 2021. Wiley Online Library; 2021. p. 9–18.

    Google Scholar 

  51. McPhail S, Haines T. Response shift, recall bias and their effect on measuring change in health-related quality of life amongst older hospital patients. Health Qual Life Outcomes. 2010;8:1–9.

    Article  Google Scholar 

  52. Ferner RE, Aronson JK. Laughter and MIRTH (methodical investigation of risibility, therapeutic and harmful): narrative synthesis. BMJ 2013, 347.

Download references

Acknowledgements

The authors hereby extend their sincere gratitude to the heads of the Radiotherapy Center, the Oncology Center, the Psychology Center, the educational supervisor, the head nurse, and the nurses working at the Reza Radiotherapy and Oncology Center, Mashhad, Iran.

Funding

This study was a part of Master’s Thesis in Medical-Surgical Nursing with project code no. 970132. To carry out this study, Dr. Seyyed Reza Mazlum obtained a fund by the Vice-Chancellor’s Office for Research at Mashhad University of Medical Sciences, Mashhad, Iran.

Author information

Authors and Affiliations

  1. Department of Nursing, School of Nursing and Midwifery, Torbat Heydariyeh University of Medical Sciences, Torbat Heydariyeh, Iran

    Mohammad Namazinia

  2. Department of Medical Surgical Nursing, School of Nursing and Midwifery, Mashhad University of Medical Sciences, Mashhad, Iran

    Mohammad Namazinia & Seyyed Reza Mazlum

  3. Nursing and Midwifery Care Research Center, Mashhad University of Medical Sciences, Mashhad, Iran

    Seyyed Reza Mazlum & Samira Mohajer

  4. Department of Nursing Science, Faculty of Medicine, University of Malaya, Kuala Lumpur, Malaysia

    Samira Mohajer

  5. School of Nursing, Midwifery and Social Sciences, Central Queensland University, Queensland, Australia

    Violeta Lopez

Authors
  1. Mohammad Namazinia
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Seyyed Reza Mazlum
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Samira Mohajer
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Violeta Lopez
    View author publications

    You can also search for this author in PubMed Google Scholar

Contributions

MN, prepared the writing of the initial draft, acquisition of data, analyze and interpret the data, conceptualize the paper, and review and synthesize the literature. SRM, obtained funding for the manuscript, supervised, proof-read, and provided intellectual support in terms of statistical analysis and administrative, technical, and material support and supervised in the preparation of the manuscript. SM, supervised, proof-read, and provided intellectual support in terms of administrative, technical, and material support and supervised in the preparation of the manuscript. VL, provided critical review and significant revision of the manuscript for important intellectual content, proof-read, and supervised the preparation of the manuscript. All authors read and approved the final manuscript.

Corresponding authors

Correspondence to Samira Mohajer or Violeta Lopez.

Ethics declarations

Ethics approval and consent to participate

The research was approved by the Research Ethics Committees of Mashhad University of Medical Sciences, Mashhad, Iran (no. IR.MUMS.NURSE.REC.1397.021). The approval was gained from the Director of Reza Radiotherapy and Oncology Center managers and head nurse. Before obtaining consent, researcher approached the patients and informed about the purpose, interventions, benefit, risk and outcome of the study. Upon obtained consent from the cancer patients, data was collected at baseline (before the intervention) and right after the last laughter yoga session. The questionnaire was administered by the same researcher. cancer patients were asked to respond to each item and upon completion, return this to the researcher. To maintain the confidentiality and privacy the identifying information was anonymized. The cancer patients were also informed that they can withdrew from the study at any time. All methods were performed in accordance with the relevant guidelines and regulations, which are aligned with the Declaration of Helsinki.

Consent for publication

Not applicable.

Competing interests

The authors declare no competing interests.

Additional information

Publisher’s Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Electronic supplementary material

Below is the link to the electronic supplementary material.

Supplementary Material 1

Rights and permissions

Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data.

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Namazinia, M., Mazlum, S.R., Mohajer, S. et al. Effects of laughter yoga on health-related quality of life in cancer patients undergoing chemotherapy: a randomized clinical trial. BMC Complement Med Ther 23, 192 (2023). https://doi.org/10.1186/s12906-023-04028-2

Download citation

  • Received:

  • Accepted:

  • Published:

  • DOI: https://doi.org/10.1186/s12906-023-04028-2

Keywords

BMC Complementary Medicine and Therapies

ISSN: 2662-7671

Contact us